BHVN Q3 2021 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$55M

Net Income

-$54M

EPS (Diluted)

$-1.52

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$44M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$1.7B

Stockholders' Equity

-$588M

Cash & Equivalents

$501M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$18M	-100.0%
Gross Profit	$0	$13M	-100.0%
Operating Income	-$55M	-$163M	+66.0%
Net Income	-$54M	-$195M	+72.1%